Kusajili – Clinical trials directory

Result of your search per sponsor: Freistaat Bayern, vertreten durch Klinikum der Universität Regensburg

Woman and Man Max 99 years
Freistaat Bayern, vertreten durch Klinikum der Universität Regensburg Update Il y a 4 ans

Prospective, randomised (using minimisation), double-blind, placebo controlled study to evaluate the safety and efficacy of human normal immunoglobulin as a prophylactic agent against infections in patients with high grade gliomas To determine the number of infective episodes in patients with high grade gliomas during treatment with 10% intravenous immunoglobulin (Kiovig) compared with placebo (normal saline).

Country None
organs None
Specialty None

Closed trial

More information